Mechanisms involved in antibody- and complement-mediated allograft rejection
- 5 February 2010
- journal article
- research article
- Published by Springer Nature in Immunologic Research
- Vol. 47 (1-3) , 25-44
Abstract
Antibody-mediated rejection has become critical clinically because this form of rejection is usually unresponsive to conventional anti-rejection therapy, and therefore, it has been recognized as a major cause of allograft loss. Our group developed experimental animal models of vascularized organ transplantation to study pathogenesis of antibody- and complement-mediated endothelial cell injury leading to graft rejection. In this review, we discuss mechanisms of antibody-mediated graft rejection resulting from activation of complement by C1q- and MBL (mannose-binding lectin)-dependent pathways and interactions with a variety of effector cells, including macrophages and monocytes through Fcγ receptors and complement receptors.Keywords
This publication has 158 references indexed in Scilit:
- Accommodation in organ transplantationCurrent Opinion in Organ Transplantation, 2008
- Accommodation of grafts: Implications for health and diseaseHuman Immunology, 2007
- Antibody to human leukocyte antigen triggers endothelial exocytosisProceedings of the National Academy of Sciences, 2007
- HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathwayTransplant Immunology, 2006
- Detection and specification of noncomplement binding anti-HLA alloantibodiesHuman Immunology, 2004
- Mechanism for in vitro “accommodation” of human aortic endothelial cells by alloantibodies specific for HLA molecules: down regulation of adhesion molecules and over expression of protective genesHuman Immunology, 2002
- Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbαJournal of Experimental Medicine, 1998
- A Detailed Lectin Analysis of IgG Glycosylation, Demonstrating Disease Specific Changes in Terminal Galactose and N-acetylglucosamineJournal of Autoimmunity, 1997
- Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsImmunology Today, 1993
- Vascular deposition of complement-split products in kidney allografts with cell-mediated rejectionClinical and Experimental Immunology, 1991